Generation Investment Management, an investment management firm, released its “Global Equity Strategy” fourth quarter 2024 ...

Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

Shares of Becton Dickinson & Co. BDX slipped 2.13% to $221.59 Thursday, on what proved to be an all-around dismal trading ...

Becton, Dickinson and Co. also reported slightly higher pay for the device developer and manufacturer's median worker in ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...

Shares of Becton, Dickinson and Company stock opened at $226.04 on Wednesday. The company’s 50 day moving average price is $231.38 and its two-hundred day moving average price is $231.62. The ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here.

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

Based in Franklin Lakes, NJ, Becton, Dickinson and Company, commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices ...

In its fourth quarter 2024 investor letter, Generation Global Equity Strategy emphasized stocks such as Becton, Dickinson and Company (NYSE:BDX). Becton, Dickinson and Company (NYSE:BDX ...